Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dennis Emma is active.

Publication


Featured researches published by Dennis Emma.


Gynecologic Oncology | 1992

Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy

Jeffrey D. Bloss; Michael L. Berman; J. Mukhererjee; Alberto Manetta; Dennis Emma; Nilam S. Ramsanghani; Philip J. DiSaia

The management of bulky, stage IB cervical carcinoma remains controversial. The present study reports the outcome of 84 women treated by radical hysterectomy, in which the surgical specimen revealed a lesion measured to be 4 cm or greater in size following formalin fixation. Of the 84 women, 42 (50%) received postoperative radiotherapy based on additional surgical findings beyond tumor size suggesting a high risk for pelvic recurrence including lymph node metastasis, parametrial spread, and compromised margins. Despite the bulky nature of these lesions, major operative and early postoperative complication rates were low (6%). Delayed complications including fistulae and bowel obstructions occurred in only 2.4% of patients treated with surgery alone and in 14.2% of women treated with combined therapy. Corrected 5-year survival in this series was 70.4% (75.6% in the surgery only group and 65.0% in the surgery plus radiotherapy group). Recurrence and mortality rates were related to lesion size, with most recurrences and deaths occurring in women with lesions measuring 6 cm or greater. Comparison of these data utilizing primary radical hysterectomy followed by tailored radiotherapy with previously published data on similar groups of high-risk patients treated with either radiotherapy alone or with radiotherapy followed by simple hysterectomy suggests comparable survival and morbidity.


American Journal of Obstetrics and Gynecology | 1992

Radical hysterectomy in the elderly patient : analysis of morbidity

C. Fuchtner; Alberto Manetta; Joan L. Walker; Dennis Emma; Michael L. Berman; Philip J. DiSaia

Summary OBJECTIVE : This study compares the perioperative morbidity and mortality following radical hysterectomyof patients older than 65 years with a younger age group who underwent radical hysterectomy and pelvic lymphadenectomy for cervical carcinoma stage IB or IIA. STUDY DESIGN : A retrospective analysis of morbidity and mortality for the first 60 postoperative dayswas conducted. The study population of 45 women >65 years of age with cervical cancer treated by radical hysterectomy was compared with a control population of 90 women RESULTS : In the elderly group, 31 of 45 and 12 of 15 were American Society of AnesthesologistsPhysical Status II and III respectively; 68/90 and 19/90 were American Society of Anesthesiologists status I and II in the younger age group ( p = 0.001). Transfusions of >2 units were required in 14% of the elderly and 35% of younger patients ( p = 0.02). No statistical differences were observed between groups for other parameters examined. CONCLUSION : Age alone should not be a contraindication for radical hysterectomy in the elderly patientwith American Society of Anesthesiologists Physical Status I to III


Fertility and Sterility | 1995

Inhibition of growth of human ovarian cancer in nude mice by luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75*)†‡

Alberto Manetta; Gisela Gamboa-Vujicic; Potenciano Paredes; Dennis Emma; Shu Liao; Lily Leong; Barbara Asch; Andrew Schally

OBJECTIVE To report on the in vitro and in vivo inhibitory effects of LH-releasing hormone (LH-RH) antagonist Cetrorelix (SB-75; Asta Medica, Frankfurt-Main, Germany) against a panel of human ovarian carcinomas. INTERVENTIONS IN VITRO STUDIES the effect of SB-75 was measured using a standardized chemosensitivity assay in the following ovarian cancer cell lines: UCI 101; UCI 107; PA-1; NIH: OVCAR 3; UCLA: 222; A2780, parental; A2780-CR, cisplatin resistant; A2780-DR, doxorubicin resistant; and the human breast cancer cell line, MCF-7. Results were expressed as percent growth inhibition determined by crystal violet photometric analysis. In vivo studies: the antiproliferative effect of this agent was examined using UCI-107, a primary epithelial ovarian carcinoma cell line, in a nude mouse model. On day 0, 10 x 10(6) UCI 107 cells were implanted subcutaneously into 20 intact female athymic nude mice (5 to 6 weeks old). On day 8, the mice were randomly divided into two groups of 10; control mice were implanted with miniosmotic pumps filled with a vehicle solution consisting of 5.2% mannitol in saline; and treated animals received pumps filled to deliver continuous administration of SB-75 at 60 micrograms per mouse per day. RESULTS IN VITRO STUDIES direct inhibition of cell proliferation by SB-75 was not observed at concentrations ranging from 1 nM to 100 microM (exposure lasting three to four cell doublings) with the exception of MCF-7, which demonstrated a 33% inhibition at the latter concentration. In vivo studies: on day 16, caliper measurements were taken from subcutaneous tumor nodules in SB-75-treated and untreated mice and a significant difference of 270% in mean tumor volume was observed. End point was determined, on day 30, when control tumor volume approached 10,000 mm3. At that time the difference in mean tumor volumes increased to 600%, indicating a substantial antiproliferative effect had been achieved in the SB-75-treated group. CONCLUSION Our in vitro findings show direct inhibition by SB-75 on proliferation of human breast cancer cells. This direct inhibition in vitro was not observed in our ovarian cancer cell lines. However, in vivo SB-75 caused a significant inhibition of growth of human epithelial ovarian cancer. This may be a result of inhibition of the pituitary gonadal axis and gonadotropin secretion. Our results warrant further investigation.


American Journal of Obstetrics and Gynecology | 1993

Effects of rotation discipline on medical student grades in obstetrics and gynecology throughout the academic year

Alberto Manetta; Edward Manetta; Dennis Emma; K.A. Keegan; J.H. Williams

OBJECTIVES Our purpose was to determine whether the sequence of rotation disciplines taken can effect medical student examination scores on the National Board of Medical Examiners Subject Exam score for obstetrics and gynecology. STUDY DESIGN A retrospective study was conducted of 439 student files for the academic years 1987 through 1991. The final clerkship grades and subject examination scores for internal medicine, pediatrics, psychiatry, surgery, and obstetrics and gynecology were reviewed. RESULTS It was determined that completion of internal medicine or surgery before obstetrics and gynecology yielded higher scores in obstetrics and gynecology (p < 0.00001), with the largest improvement (from 533 to 586) observed when obstetrics and gynecology followed the internal medicine rotation. CONCLUSION The sequence of rotation can affect scores on the National Board of Medical Examiners subject examination in obstetrics and gynecology. The largest improvement in student scores was observed when obstetrics and gynecology followed the internal medicine or surgery clerkships.


Gynecologic Oncology | 1991

Radical hysterectomy in the elderly patient: Analysis of morbidity

C. Fuchtner; Alberto Manetta; Joan L. Walker; Dennis Emma; Michael L. Berman; P.J. DiSaia

OBJECTIVE This study compares the perioperative morbidity and mortality following radical hysterectomy of patients older than 65 years with a younger age group who underwent radical hysterectomy and pelvic lymphadenectomy for cervical carcinoma stage IB or IIA. STUDY DESIGN A retrospective analysis of morbidity and mortality for the first 60 postoperative days was conducted. The study population of 45 women greater than 65 years of age with cervical cancer treated by radical hysterectomy was compared with a control population of 90 women less than 65 years treated similarly. RESULTS In the elderly group, 31 of 45 and 12 of 15 were American Society of Anesthesologists Physical Status II and III respectively; 68/90 and 19/90 were American Society of Anesthesiologists status I and II in the younger age group (p = 0.001). Transfusions of greater than 2 units were required in 14% of the elderly and 35% of younger patients (p = 0.02). No statistical differences were observed between groups for other parameters examined. CONCLUSION Age alone should not be a contraindication for radical hysterectomy in the elderly patient with American Society of Anesthesiologists Physical Status I to III.


Gynecologic Oncology | 1996

Novel Phosphonium Salts Displayin Vitroandin VivoCytotoxic Activity against Human Ovarian Cancer Cell Lines

Alberto Manetta; Gisela Gamboa; Amir Nasseri; Yale D. Podnos; Dennis Emma; Guillermo Dorion; Luke Rawlings; Philip M. Carpenter; Andres Bustamante; Jasmin Patel; Darryl Rideout


Gynecologic Oncology | 1993

Measurement of the Soluble Membrane Receptors for Tumor Necrosis Factor and Lymphotoxin in the Sera of Patients with Gynecologic Malignancy

Elizabeth A. Grosen; Gale A. Granger; Maki Gatanaga; Elizabeth K. Ininns; Chenduen Hwang; Philip J. DiSaia; Michael L. Berman; Alberto Manetta; Dennis Emma; Tetsuya Gatanaga


Gynecologic Oncology | 1993

Characterization of a Human Ovarian Carcinoma Cell Line: UCI 101

C. Fuchtner; Dennis Emma; Alberto Manetta; Gisela Gamboa; R. Bernstein; Shu-Yuan Liao


Journal of Pharmaceutical Sciences | 1993

Toxicity of the Mitochondrial Poison Dequalinium Chloride in a Murine Model System

Gisela Gamboa-Vujicic; Dennis Emma; Shu Y. Liao; C. Fuchtner; Alberto Manetta


Gynecologic Oncology | 1993

Failure to Enhance the in Vivo Killing of Human Ovarian Carcinoma by Sequential Treatment with Dequalinium Chloride and Tumor Necrosis Factor

Alberto Manetta; Dennis Emma; Gisela Gamboa; Shu Liao; Michael L. Berman; Philip J. DiSaia

Collaboration


Dive into the Dennis Emma's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Fuchtner

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gisela Gamboa

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shu Liao

University of California

View shared research outputs
Top Co-Authors

Avatar

Barbara Asch

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Mukhererjee

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge